These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 25477161)

  • 21. A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data.
    Leombruni P; Miniotti M; Colonna F; Sica C; Castelli L; Bruzzone M; Parisi S; Fusaro E; Sarzi-Puttini P; Atzeni F; Torta RG
    Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S82-5. PubMed ID: 25786048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute Poisoning During Pregnancy: Observations from the Toxicology Investigators Consortium.
    Zelner I; Matlow J; Hutson JR; Wax P; Koren G; Brent J; Finkelstein Y;
    J Med Toxicol; 2015 Sep; 11(3):301-8. PubMed ID: 25783189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.
    Hirayama Y; Ishitani K; Sato Y; Iyama S; Takada K; Murase K; Kuroda H; Nagamachi Y; Konuma Y; Fujimi A; Sagawa T; Ono K; Horiguchi H; Terui T; Koike K; Kusakabe T; Sato T; Takimoto R; Kobune M; Kato J
    Int J Clin Oncol; 2015 Oct; 20(5):866-71. PubMed ID: 25762165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid supplementation improves microvascular function in older adults through nitric oxide-dependent mechanisms.
    Stanhewicz AE; Alexander LM; Kenney WL
    Clin Sci (Lond); 2015 Jul; 129(2):159-67. PubMed ID: 25748442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful Management of Pregnancy and Hepatic Toxicity in a CML Female Patient Treated with Nilotinib: a Case Report and a Review.
    Santorsola D; Abruzzese E
    Mediterr J Hematol Infect Dis; 2015; 7(1):e2015020. PubMed ID: 25745547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience.
    Petrioli R; Francini E; Roviello F; Marrelli D; Fiaschi AI; Laera L; Rossi G; Bianco V; Brozzetti S; Roviello G
    Cancer Chemother Pharmacol; 2015 May; 75(5):941-7. PubMed ID: 25743995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy and safety of cisplatin plus pemetrexed as a first-line treatment for Japanese patients with advanced non-squamous non-small-cell lung cancer -- a retrospective analysis].
    Yamaguchi T; Nakanishi T; Hayashi M; Uozu S; Okamura T; Morishita M; Takeyama T; Minezawa T; Morikawa S; Niwa Y; Mieno Y; Kato A; Hoshino T; Isogai S; Okazawa M; Imaizumi K
    Gan To Kagaku Ryoho; 2015 Feb; 42(2):183-7. PubMed ID: 25743136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyposmia: an underestimated and frequent adverse effect of chemotherapy.
    Riga M; Chelis L; Papazi T; Danielides V; Katotomichelakis M; Kakolyris S
    Support Care Cancer; 2015 Oct; 23(10):3053-8. PubMed ID: 25739754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate.
    Chickermane PR; Khubchandani RP
    Clin Exp Rheumatol; 2015; 33(2):287-92. PubMed ID: 25738527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced testicular cancer associated with life-threatening tumour lysis syndrome and choriocarcinoma syndrome.
    Kobatake K; Kato M; Mita K
    Can Urol Assoc J; 2015; 9(1-2):62-4. PubMed ID: 25737760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.
    Turkeli M; Aldemir MN; Cayir K; Simsek M; Bilici M; Tekin SB; Yildirim N; Bilen N; Makas I
    Asian Pac J Cancer Prev; 2015; 16(3):985-9. PubMed ID: 25735393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of type four gastric cancer in our institution].
    Ito M; Takayama T; Matsumoto S; Wakatsuki K; Tanaka T; Migita K; Kunishige T; Nakade H; Nakajima Y
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2242-4. PubMed ID: 25731483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant chemotherapy for brain tumors in infants and young children.
    Iwama J; Ogiwara H; Kiyotani C; Terashima K; Matsuoka K; Iwafuchi H; Morota N
    J Neurosurg Pediatr; 2015 May; 15(5):488-92. PubMed ID: 25723725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.
    Cho H; Nishiike S; Yamamoto Y; Takenaka Y; Nakahara S; Yasui T; Hanamoto A; Inohara H
    Auris Nasus Larynx; 2015 Oct; 42(5):396-400. PubMed ID: 25721854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma.
    Guion-Dusserre JF; Lorgis V; Vincent J; Bengrine L; Ghiringhelli F
    World J Gastroenterol; 2015 Feb; 21(7):2096-101. PubMed ID: 25717243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gemcitabine + platinum combination chemotherapy in patients with metastatic cancer who suffer from severe and irreversible hepatic impairment: a single center experience.
    Sezer A; Sümbül AT; Abali H; Mertsoylu H; Muallaoğlu S; Köse F; Ozyilkan O
    Hepatogastroenterology; 2014 Oct; 61(135):1895-900. PubMed ID: 25713885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study.
    Liu Y; Yue H; Xu S; Wang F; Ma N; Li K; Qiao L; Wang J
    Int J Clin Oncol; 2015 Oct; 20(5):952-9. PubMed ID: 25712158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533.
    Wozniak AJ; Moon J; Thomas CR; Kelly K; Mack PC; Gaspar LE; Raben D; Fitzgerald TJ; Pandya KJ; Gandara DR
    Clin Lung Cancer; 2015 Sep; 16(5):340-7. PubMed ID: 25703100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
    Katsaounis P; Kotsakis A; Agelaki S; Kontopodis E; Agelidou A; Kentepozidis N; Vamvakas L; Christopoulou A; Karachaliou N; Hatzidaki D; Georgoulias V
    Cancer Chemother Pharmacol; 2015 Apr; 75(4):821-7. PubMed ID: 25702051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.
    Paz-Ares L; Mezger J; Ciuleanu TE; Fischer JR; von Pawel J; Provencio M; Kazarnowicz A; Losonczy G; de Castro G; Szczesna A; Crino L; Reck M; Ramlau R; Ulsperger E; Schumann C; Miziara JE; Lessa ÁE; Dediu M; Bálint B; Depenbrock H; Soldatenkova V; Kurek R; Hirsch FR; Thatcher N; Socinski MA;
    Lancet Oncol; 2015 Mar; 16(3):328-37. PubMed ID: 25701171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.